SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:liu-184700"
 

Sökning: onr:"swepub:oai:DiVA.org:liu-184700" > Global disparities ...

  • Tromp, JasperNatl Univ Singapore, Singapore; Natl Univ Hlth Syst, Singapore; Duke Natl Univ, Singapore; Univ Groningen, Netherlands (författare)

Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction

  • Artikel/kapitelEngelska2022

Förlag, utgivningsår, omfång ...

  • 2022-04-08
  • OXFORD UNIV PRESS,2022
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:liu-184700
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-184700URI
  • https://doi.org/10.1093/eurheartj/ehac103DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Background Heart failure (HF) is a global challenge, with lower- and middle-income countries (LMICs) carrying a large share of the burden. Treatment for HF with reduced ejection fraction (HFrEF) improves survival but is often underused. Economic factors might have an important effect on the use of medicines. Methods and results This analysis assessed prescription rates and doses of renin-angiotensin system (RAS) inhibitors, beta-blockers, and mineralocorticoid receptor antagonists at discharge and 6-month follow-up in 8669 patients with HFrEF (1458 from low-, 3363 from middle-, and 3848 from high-income countries) hospitalized for acute HF in 44 countries in the prospective REPORT-HF study. We investigated determinants of guideline-recommended treatments and their association with 1-year mortality, correcting for treatment indication bias. Only 37% of patients at discharge and 34% of survivors at 6 months were on all three medication classes, with lower proportions in LMICs than high-income countries (19 vs. 41% at discharge and 15 vs. 37% at 6 months). Women and patients without health insurance, or from LMICs, or without a scheduled medical follow-up within 6 months of discharge were least likely to be on guideline-recommended medical therapy at target doses, independent of confounders. Being on >= 50% of guideline-recommended doses of RAS inhibitors, and beta-blockers were independently associated with better 1-year survival, regardless of country income level. Conclusion Patients with HFrEF in LMICs are less likely to receive guideline-recommended drugs at target doses. Improved access to medications and medical care could reduce international disparities in outcome.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Ouwerkerk, WouterNatl Heart Ctr Singapore, Singapore; Univ Amsterdam, Netherlands (författare)
  • Teng, Tiew-Hwa K.Duke Natl Univ, Singapore; Natl Heart Ctr Singapore, Singapore (författare)
  • Cleland, John G. F.Univ Glasgow, England; Imperial Coll, England (författare)
  • Bamadhaj, SahiddahNatl Heart Ctr Singapore, Singapore (författare)
  • Angermann, Christiane E.Univ Hosp Wurzburg, Germany; Univ Hosp Wurzburg, Germany (författare)
  • Dahlström, UlfLinköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Region Östergötland, Kardiologiska kliniken US(Swepub:liu)ulfda85 (författare)
  • Tay, Wan TingNatl Heart Ctr Singapore, Singapore (författare)
  • Dickstein, KennethUniv Bergen, Norway (författare)
  • Ertl, GeorgUniv Hosp Wurzburg, Germany; Univ Hosp Wurzburg, Germany (författare)
  • Hassanein, MahmoudAlexandria Univ, Egypt (författare)
  • Perrone, Sergio VEl Cruce Hosp Florencio Varela, Argentina (författare)
  • Ghadanfar, MathieuM Ghadanfar Consulting Life Sci, Switzerland (författare)
  • Schweizer, AnjaNovartis Pharma AG, Switzerland (författare)
  • Obergfell, AchimNovartis Pharma AG, Switzerland (författare)
  • Collins, Sean P.Vanderbilt Univ, TN USA (författare)
  • Filippatos, GerasimosUniv Cyprus, Greece; Natl & Kapodistrian Univ Athens, Greece (författare)
  • Lam, Carolyn S. P.Duke Natl Univ, Singapore; Univ Groningen, Netherlands; Natl Heart Ctr Singapore, Singapore (författare)
  • Natl Univ Singapore, Singapore; Natl Univ Hlth Syst, Singapore; Duke Natl Univ, Singapore; Univ Groningen, NetherlandsNatl Heart Ctr Singapore, Singapore; Univ Amsterdam, Netherlands (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:European Heart Journal: OXFORD UNIV PRESS43:23, s. 2224-22340195-668X1522-9645

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy